Patient characteristics | Experimental group | Control group | ||
---|---|---|---|---|
Age | 31.8 ± 12.1 | 31.2 ± 5.3 | ||
Sex | M:9; F:7 | M:9; F:7 | ||
Disease | ||||
Allergic rhinitis | 15 | (93.8 %) | 0 | |
Asthma | 10 | (62.5 %) | 0 | |
Allergic conjunctivitis | 14 | (87.5 %) | 0 | |
Atopic dermatitis | 1 | (6.25 %) | 0 | |
Skin prick test positivity | ||||
Alder | 13 | (81.3 %) | 0 | |
Hazel | 13 | (81.3 %) | 0 | |
Birch | 12 | (75.0 %) | 0 | |
Grass | 11 | (68.8 %) | 0 | |
Specific IgE level for skin prick test—positive patients [IU/l] | ||||
Alder | 15.3 ± 19.7 | N.A. | ||
Hazel | 5.5 ± 7.5 | N.A. | ||
Birch | 56.0 ± 39.2 | N.A. | ||
Grass | 43.1 ± 46.4 | N.A. | ||
Specific IgE level for dominant allergen [IU/l] | 41.0 ± 43.7 | N.A. | ||
Currently smoking | 2 | (12.5 %) | 1 | (6.25 %) |
Treatment | ||||
Inhaled steroid | 7 | (43.8 %) | 0 | |
Short acting β2-mimetic | 2 | (12.5 %) | 0 | |
Montelukast | 2 | (12.5 %) | 0 | |
Long acting β2-mimetic | 1 | (6.25 %) | 0 |